Autoinjectors Market - Global Forecast to 2024
- December, 2018
- Domain: Healthcare - Medical Devices
- Get Free 10% Customization in this Report
[95 Report Pages] This market research report identifies Mylan NV, Novartis AG, Amgen, Inc., Becton Dickinson and Company, Bayer AG, and Eli Lilly & Company Ltd as the major vendors operating in the global autoinjectors market. This report also provides a detailed analysis of the market by application (Anaphylaxis, Multiple sclerosis, Rheumatoid arthritis, Diabetes, and Others), product type (Disposable autoinjectors and Reusable autoinjectors), and region (North America, Europe, Asia Pacific, and Rest of the World).
Overview of the Autoinjectors Market
Infoholic’s market research report predicts that the global autoinjectors market will grow at a CAGR of 17.1% during the forecast period 2018–2024. The raising prevalence of serious medical conditions such as anaphylaxis & other food allergies, advancements in the autoinjectors technology, increasing demand for home healthcare, and the rising need for self-injectors are the factors aiding the growth of the autoinjectors market. Novel formulations of drugs and advancements in drug delivery systems along with favorable government regulations are providing an opportunity for market growth. However, recent product recalls by the companies and the availability of substitutes for autoinjectors are hampering the market growth.
According to the autoinjectors market analysis, in 2017, North America accounts for the largest share of the autoinjectors market, followed by Europe, Asia Pacific, and Rest of the World. More than 65% of the market is occupied by North America, with the US being the major contributor to the market growth.
Competitive Analysis and Key Vendors
The key manufacturers of autoinjectors are concentrating on innovative marketing tactics to expand the reach of their products globally. Increasing awareness campaigns and price reduction of branded devices are among the strategies used by the leading companies to manage intense competition in the market. Many companies are rebranding their autoinjectors with worthwhile reductions in the price. In December 2016, Mylan launched the generic version of EpiPen to provide autoinjectors for customers at lesser prices. This approach ought to help the company in targeting a larger customer pool, thus increasing the company’s customer base in recent years.
Some of the Autoinjectors Market key vendors are:
- Mylan NV
- Novartis AG
- Amgen, Inc.
- Becton Dickinson and Company
- Bayer AG
- Eli Lilly & Company Ltd
The other key players in the market include Ypsomed Holding AG, Biogen Pharmaceuticals, Pfizer Inc., Teva Pharmaceutical, Antares Pharma, Inc., Johnson and Johnson, and AbbVie Inc.
Autoinjectors Market by Product
- Disposable autoinjectors
- Reusable autoinjectors
In 2017, the disposable autoinjectors hold dominant market share and is also the fastest growing segment in the market.
Autoinjectors Market by Application
- Multiple sclerosis
- Rheumatoid arthritis
In 2017, the market is dominated by anaphylaxis owing to a high prevalence rate globally. The fastest growing segment of the market is rheumatoid arthritis due to increased development of novel drugs for the treatment of the condition.
The report provides detailed information about the usage and adoption of autoinjectors in various regions. With that, key stakeholders can find out the major trends, drivers, investments, and vertical player’s initiatives toward the product adoption in the upcoming years, along with the details of commercial products available in the market. Moreover, the report provides details about the major challenges that are going to have an impact on market growth. Additionally, the report gives complete details about the business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals. The report will help companies interested or established in this market to analyze the various aspects of this domain before investing or expanding their business in the autoinjectors market.
1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Segmented Addressable Market
3.3 Industry Trends
3.4 Related Markets
3.4.1 Transdermal Drug Delivery
22.214.171.124 Trends in the transdermal drug delivery market
3.4.2 Pulmonary Drug Delivery Systems (PDDS)
3.4.3 Insulin Pumps
4 Market Outlook
4.1 Cost Comparison of EpiPen and its Alternatives
4.2 Market Segmentation
4.3 Porter 5(Five) Forces
4.4 PEST Analysis
5 Market Characteristics
5.1 Market Dynamics
126.96.36.199 Increasing prevalence of anaphylaxis
188.8.131.52 Rising incidence of chronic disease
184.108.40.206 Increased development biologics/biosimilars
220.127.116.11 Growing demand for home care
18.104.22.168 Increase in healthcare spending
22.214.171.124 Opportunities in the emerging market
126.96.36.199 Favorable government policies
188.8.131.52 Competition among major vendors
184.108.40.206 Increased product recall
220.127.116.11 High product pricing
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Applications: Market Size and Analysis
6.3 Multiple Sclerosis
6.4 Rheumatoid Arthritis
7 Product Type: Market Size and Analysis
7.2 Disposable Autoinjectors
7.3 Reusable Autoinjectors
8 Regions: Market Size and Analysis
8.2 North America
8.4 Asia Pacific
8.5 Rest of the World
9 Competitive Landscape
10 Vendors Profile
10.1 Amgen Inc.
10.1.2 Geographic Presence
10.1.3 Business Focus
10.1.4 SWOT Analysis
10.1.5 Business Strategies
10.2 Becton Dickinson and Company
10.2.2 Business Units
10.2.3 Geographic Revenue
10.2.4 Business Focus
10.2.5 SWOT Analysis
10.2.6 Business Strategies
10.3 Mylan N.V.
10.3.2 Business Segments
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Bayer AG
10.4.2 Business Units
10.4.3 Geographic Presence
10.4.4 Business Focus
10.4.5 SWOT Analysis
10.4.6 Business Strategies
10.5 Eli Lilly & Company Ltd.
10.5.2 Business Units
10.5.3 Geographic Revenue
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
10.6 Novartis AG
10.6.2 Business Units
10.6.3 Geographic Presence
10.6.4 Business Focus
10.6.5 SWOT Analysis
10.6.6 Business Strategies
11 Companies to Watch for
11.1 Ypsomed Holding AG
11.2 Biogen Pharmaceuticals
11.3 Pfizer Inc.
11.4 Teva Pharmaceutical Industries Ltd.
11.5 Antares Pharma Inc.
11.6 Johnson & Johnson
11.7 AbbVie Inc.
TABLE 1 AUTOINJECTOR MARKET REVENUE BY APPLICATION SEGMENTATION, 2017–2024 ($MILLION) 33
TABLE 2 PREVALENCE OF DIABETES POPULATION FORECASTING BY REGION 37
TABLE 3 AUTOINJECTOR MARKET REVENUE BY REGIONS, 2017–2024 ($MILLION) 44
TABLE 4 AMGEN INC.: OFFERINGS 51
TABLE 5 AMGEN INC.: RECENT DEVELOPMENTS 51
TABLE 6 BECTON DICKINSON AND COMPANY: OFFERINGS 58
TABLE 7 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS 58
TABLE 1 MYLAN N.V.: OFFERINGS 63
TABLE 2 MYLAN N.V.: RECENT DEVELOPMENTS 63
TABLE 3 BAYER AG: OFFERINGS 68
TABLE 4 BAYER AG: RECENT DEVELOPMENTS 68
TABLE 5 ELI LILLY & COMPANY LTD.: PRODUCT OFFERINGS 72
TABLE 6 ELI LILLY & COMPANY LTD.: RECENT DEVELOPMENTS 73
TABLE 7 NOVARTIS AG: OFFERINGS 77
TABLE 8 NOVARTIS AG: RECENT DEVELOPMENTS 78
TABLE 9 YPSOMED HOLDING AG: SNAPSHOT 83
TABLE 10 YPSOMED HOLDING AG: RECENT DEVELOPMENTS 83
TABLE 11 BIOGEN PHARMACEUTICALS: OVERVIEW 84
TABLE 12 BIOGEN PHARMACEUTICALS: RECENT DEVELOPMENTS 84
TABLE 13 PFIZER INC. OVERVIEW 85
TABLE 14 PFIZER INC.: RECENT DEVELOPMENTS 86
TABLE 15 TEVA PHARMACEUTICAL INDUSTRIES LTD. OVERVIEW 87
TABLE 16 TEVA PHARMACEUTICAL INDUSTRIES LTD.: RECENT DEVELOPMENTS 88
TABLE 17 ANTARES PHARMA, INC.: OVERVIEW 89
TABLE 18 ANTARES PHARMA, INC.: RECENT DEVELOPMENTS 89
TABLE 19 JOHNSON & JOHNSON: OVERVIEW 90
TABLE 20 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 90
TABLE 21 ABBVIE INC.: OVERVIEW 91
TABLE 22 ABBVIE INC.: RECENT DEVELOPMENTS 92
Infoholic Research works on a holistic 360° approach in order to deliver high quality, validated and reliable information in our market reports. The Market estimation and forecasting involves following steps:
- Data Collation (Primary & Secondary)
- In-house Estimation (Based on proprietary data bases and Models)
- Market Triangulation
Market related information is congregated from both primary and secondary sources.
Involved participants from all global stakeholders such as Solution providers, service providers, Industry associations, thought leaders etc. across levels such as CXOs, VPs and managers. Plus, our in-house industry experts having decades of industry experience contribute their consulting and advisory services.
Include public sources such as regulatory frameworks, government IT spending, government demographic indicators, industry association statistics, and company publications along with paid sources such as Factiva, OneSource, Bloomberg among others.